Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Gon

Showing results (161-170 of 177) with videos related to

Pageof 18
Sort By:
Thoracic Cancer|January 20, 2024
Relationship between patterns of immunohistochemical conventional neuroendocrine markers and efficacy of immune check point inhibitors in patients with extensive disease small cell lung cancerYuko Iida, Kazushige Wakuda, Takuya Kawata, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 28, 2025
The efficacy and safety of Fluticasone Furoate/Umeclidinium/vilanterol (FF/UMEC/VI) on cough symptoms in adult patients with asthma, a randomized double-blind, placebo-controlled, parallel group study: Chronic Cough in Asthma (COCOA) studyEtsuko Tagaya, Jun Shinada, Hiroyuki Nagase, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|June 14, 2025
Corrigendum to "Effectiveness of benralizumab in the Tokyo Asthma Study (TOAST): A real-world prospective interventional trial" [Allergol Int 74 (2025) 274-82]Katsunori Masaki, Maho Suzukawa, Hitoshi Sasano, et al.
Thoracic Cancer|April 25, 2026
Efficacy of Osimertinib in Patients With Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR MutationsYuko Iida, Hirotsugu Kenmotsu, Keita Mori, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|December 4, 2024
Effectiveness of benralizumab in the Tokyo Asthma Study (TOAST): A real-world prospective interventional trialKatsunori Masaki, Maho Suzukawa, Hitoshi Sasano, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|January 14, 2025
Advantage of spirometry over oscillometry to detect dupilumab's effect on small airway dysfunctionToshihiro Shirai, Keita Hirai, Taisuke Akamatsu, et al.
International Journal of Clinical Oncology|January 6, 2024
Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencingKazushige Wakuda, Meiko Morita, Motoki Sekikawa, et al.
The Journal of Allergy and Clinical Immunology|May 27, 2026
Differential responses of group 2 innate lymphoid cells and T<sub>H</sub>2 cells to benralizumab in severe asthmaMisato Irie, Hiroki Kabata, Takashi Kamatani, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|January 23, 2025
Real-world effectiveness of mepolizumab in Japanese asthma patients with diverse backgrounds: Improvements in rhinosinusitis imaging (J-Real-Mepo)Hiroyuki Nagase, Konomi Kobayashi, Makiko Toma-Hirano, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|September 14, 2024
Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthmaKenji Mizumura, Yasuhiro Gon, Norihiro Harada, et al.
Pageof 18

Showing results (161-170 of 177) with videos related to

Sort By:
Pageof 18
Thoracic Cancer|January 20, 2024
Relationship between patterns of immunohistochemical conventional neuroendocrine markers and efficacy of immune check point inhibitors in patients with extensive disease small cell lung cancerYuko Iida, Kazushige Wakuda, Takuya Kawata, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 28, 2025
The efficacy and safety of Fluticasone Furoate/Umeclidinium/vilanterol (FF/UMEC/VI) on cough symptoms in adult patients with asthma, a randomized double-blind, placebo-controlled, parallel group study: Chronic Cough in Asthma (COCOA) studyEtsuko Tagaya, Jun Shinada, Hiroyuki Nagase, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|June 14, 2025
Corrigendum to "Effectiveness of benralizumab in the Tokyo Asthma Study (TOAST): A real-world prospective interventional trial" [Allergol Int 74 (2025) 274-82]Katsunori Masaki, Maho Suzukawa, Hitoshi Sasano, et al.
Thoracic Cancer|April 25, 2026
Efficacy of Osimertinib in Patients With Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR MutationsYuko Iida, Hirotsugu Kenmotsu, Keita Mori, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|December 4, 2024
Effectiveness of benralizumab in the Tokyo Asthma Study (TOAST): A real-world prospective interventional trialKatsunori Masaki, Maho Suzukawa, Hitoshi Sasano, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|January 14, 2025
Advantage of spirometry over oscillometry to detect dupilumab's effect on small airway dysfunctionToshihiro Shirai, Keita Hirai, Taisuke Akamatsu, et al.
International Journal of Clinical Oncology|January 6, 2024
Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencingKazushige Wakuda, Meiko Morita, Motoki Sekikawa, et al.
The Journal of Allergy and Clinical Immunology|May 27, 2026
Differential responses of group 2 innate lymphoid cells and T<sub>H</sub>2 cells to benralizumab in severe asthmaMisato Irie, Hiroki Kabata, Takashi Kamatani, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|January 23, 2025
Real-world effectiveness of mepolizumab in Japanese asthma patients with diverse backgrounds: Improvements in rhinosinusitis imaging (J-Real-Mepo)Hiroyuki Nagase, Konomi Kobayashi, Makiko Toma-Hirano, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|September 14, 2024
Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthmaKenji Mizumura, Yasuhiro Gon, Norihiro Harada, et al.
Pageof 18